Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
355.20
+1.14 (+0.32%)
Official Closing Price
Updated: 4:15 PM EDT, Jun 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
66
67
Next >
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
↗
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
↗
November 15, 2023
Via
Benzinga
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors
↗
November 10, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
↗
November 10, 2023
Don't give up on these stocks too fast.
Via
The Motley Fool
20 Analysts Have This to Say About Amgen
↗
November 09, 2023
Via
Benzinga
Amgen's Rare Autoimmune Disease Candidate Shows Improvement In Disease Burden In Treating Sjögren's Syndrome
↗
November 08, 2023
Amgen Inc (NASDAQ: AMGN) released new
Via
Benzinga
Earnings Outlook For Amgen
↗
October 30, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
↗
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Performance Comparison: Amgen And Competitors In Biotechnology Industry
↗
October 27, 2023
Via
Benzinga
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
↗
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Amgen Wins Big With FDA, Analyst Sees Soaring Potential
↗
November 02, 2023
The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson's (NYSE: JNJ) psoriasis treatment, Stelara, for multiple inflammatory diseases sent
Via
Benzinga
These Analysts Revise Their Forecasts On Amgen After Q3 Results
↗
November 01, 2023
Amgen Inc (NASDAQ: AMGN) reported mixed third-quarter financial results.
Via
Benzinga
5 Dow stocks to track during the market correction
November 01, 2023
The Dow Jones Industrial Average is struggling in correction territory, but savvy investors keep an eye on resilient stocks like Microsoft, Amgen, and Walmart.
Via
MarketBeat
Topics
ETFs
Stocks
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
Via
Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
November 01, 2023
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END
Via
FinancialNewsMedia
Investor patience tested as pharmaceutical stocks take a tumble
November 01, 2023
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector
Via
MarketBeat
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
↗
November 01, 2023
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely...
Via
Benzinga
Topics
Economy
10 Health Care Stocks Whale Activity In Today's Session
↗
October 31, 2023
Via
Benzinga
Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200
↗
October 31, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Economy
Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why
↗
October 31, 2023
Amgen Inc (NASDAQ: AMGN) reported Q3 FY23 sales of $6.90 billion, slightly missin
Via
Benzinga
Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel Sales
↗
October 31, 2023
The company just finished its acquisition of Horizon Therapeutics this month.
Via
Investor's Business Daily
U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive
↗
October 31, 2023
US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision.
Via
Benzinga
Topics
Economy
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
↗
October 30, 2023
This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.
Via
The Motley Fool
2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now
↗
October 29, 2023
These two defensive dividend stocks sport compelling valuations and attractive yields.
Via
The Motley Fool
Topics
Stocks
Microsoft Leads These 5 Dow Jones Stocks Near Buy Points
↗
October 28, 2023
Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.
Via
Investor's Business Daily
Topics
Stocks
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
↗
October 27, 2023
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S....
Via
Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
↗
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
3 Pharma Stocks That Are Screaming Buys in October
↗
October 26, 2023
Each company delivers an above-average dividend and revenue growth.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
October 25, 2023
Via
Benzinga
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030
October 25, 2023
EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END
Via
FinancialNewsMedia
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
66
67
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
